Skip to main content

Table 4 Functional performance at M6, in remitted schizophrenic patients (RSWG-criteria)

From: Schizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study)

 

Remitted patients

Non-remitted patients

p

Number of patients

374 (27.7 %)

976 (72.3 %)

 

GAF total rating scorea

62.5 ± 1.5

48.3 ± 0.74

< 0.001

Social functioning

 Total rating scoreb

21.0 ± 0.19

17.2 ± 0.12

<0.001

 Social skills rating scoreb

12.8 ± 0.11

10.8 ± 0.07

<0.001

 Social roles rating scoreb

8.2 ± 0.10

6.4 ± 0.06

<0.001

  1. Values are given as mean ± SEM or as % of patients. M6, month 6 (end of study)
  2. aMaximum GAF rating score = 100
  3. bSocial functioning rating scores = total (from 7 to 28), social skills (from 4 to 16) and social roles (from 3 to 12)